Interferon alfa-2A and ribavirin therapy for hepatitis C recurrence after liver transplantation

被引：8
|
作者：
Wietzke, P
Braun, F
Ringe, B
Ramadori, G
机构：
[1] Univ Gottingen, Abt Gastroenterol & Endokrinol, D-37075 Gottingen, Germany
[2] Univ Gottingen, Klin Transplantat Chirurg, D-37075 Gottingen, Germany
来源：
TRANSPLANTATION PROCEEDINGS | 2000年 / 32卷 / 07期
关键词：
D O I：
10.1016/S0041-1345(00)01782-6
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：2539 / 2542
页数：4
相关论文
共 50 条
  • [31] Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Hepatitis C
    Hsu, Ching-Sheng
    Kao, Jia-Horng
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (18): : 1808 - 1809
  • [32] Combination of "low-dose" ribavirin and interferon alfa-2a therapy followed by interferon alfa-2a monotherapy in chronic HCV-infected nonresponders and relapsers after interferon alfa-2a monotherapy
    Perdita Wietzke-Braun
    Volker Meier
    Felix Braun
    Giuliano Ramadori
    World Journal of Gastroenterology, 2001, (02) : 222 - 227
  • [33] Effect of ribavirin in genotype 1 patients with hepatitis C responding to pegylated interferon alfa-2a plus ribavirin
    Bronowicki, Jean-Pierre
    Ouzan, Denis
    Asselah, Tarik
    Desmorat, Herve
    Zarski, Jean-Pierre
    Foucher, Juliette
    Bourliere, Marc
    Renou, Christophe
    Tran, Albert
    Melin, Pascal
    Hezode, Christophe
    Chevalier, Michelle
    Bouvier-Alias, Magali
    Chevaliez, Stephane
    Montestruc, Francois
    Lonjon-Domanec, Isabelle
    Pawlotsky, Jean-Michel
    GASTROENTEROLOGY, 2006, 131 (04) : 1040 - 1048
  • [34] A randomized study on Peg-interferon alfa-2a with or without ribavirin in liver transplant recipients with recurrent hepatitis C
    Angelico, Mario
    Petrolati, Alessandra
    Lionetti, Raffaella
    Lenci, Ilaria
    Burra, Patrizia
    Donato, Maria Francesca
    Merli, Manuela
    Strazzabosco, Mario
    Tisone, Giuseppe
    JOURNAL OF HEPATOLOGY, 2007, 46 (06) : 1009 - 1017
  • [35] Pegylated interferon alfa-2a (40 kD) and ribavirin in haemodialysis patients with chronic hepatitis C
    van Leusen, Robert
    Adang, Rob P. R.
    de Vries, Richard A.
    Cnossen, Trijntje T.
    Konings, Constantijn J. A. M.
    Schalm, Solko W.
    Tan, Adriaan C. I. T. L.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2008, 23 (02) : 721 - 725
  • [36] Pegylated Interferon Alfa-2a Plus Ribavirin in Chronic Hepatitis C Patients with Genotype 6
    Pham, Thuy T.
    Ho, Dat T.
    GASTROENTEROLOGY, 2009, 136 (05) : A840 - A840
  • [37] A multidisciplinary support programme increases the efficiency of pegylated interferon alfa-2a and ribavirin in hepatitis C
    Antonio Carrion, Jose
    Gonzalez-Colominas, Elena
    Garcia-Retortillo, Montserrat
    Canete, Nuria
    Cirera, Isabel
    Coll, Susanna
    Dolors Gimenez, Maria
    Marquez, Carmen
    Martin-Escudero, Victoria
    Castellvi, Pere
    Navines, Ricard
    Ramon Castano, Juan
    Anton Galeras, Josep
    Salas, Esther
    Bory, Felipe
    Martin-Santos, Rocio
    Sola, Ricard
    JOURNAL OF HEPATOLOGY, 2013, 59 (05) : 926 - 933
  • [38] Extensive Psoriasis Induced by Pegylated Interferon Alfa-2a and Ribavirin in the Treatment of Chronic Hepatitis C
    Kim, Gun-Wook
    Jwa, Seung-Wook
    Song, Margaret
    Kim, Hoon-Soo
    Kim, Byung-Soo
    Kim, Moon-Bum
    Ko, Hyun-Chang
    ANNALS OF DERMATOLOGY, 2013, 25 (04) : 479 - 482
  • [39] PHOENIX: A Randomized Controlled Trial of Peginterferon Alfa-2a Plus Ribavirin as a Prophylactic Treatment After Liver Transplantation for Hepatitis C Virus
    Bzowej, Natalie
    Nelson, David R.
    Terrault, Norah A.
    Everson, Gregory T.
    Teng, Lichen L.
    Prabhakar, Avinash
    Charlton, Michael R.
    LIVER TRANSPLANTATION, 2011, 17 (05) : 528 - 538
  • [40] Treatment of chronic hepatitis C with pegylated interferon alfa-2a plus ribavirin in hemophiliac patients
    Malekzadeh, R
    Merat, S
    Sohrabpour, AA
    Khaleghi, S
    Samimi-Rad, K
    GASTROENTEROLOGY, 2004, 126 (04) : A431 - A431
12345